A study of the trypanocidal activity of triterpene acids isolated from Miconia species

Phytotherapy Research

Volumn 20, Issue 6, 2006, Pages 474-478

  Cunha, Wilson Roberto ^a   Crevelin, Eduardo J ^a   Arantes, Glenda M ^a   Miller Crotti, Antonio E ^a   Andrade E Silva, Márcio L ^a   Cardoso Furtado, Niege A J ^a   Albuquerque, Sérgio ^b   Da Silva Ferreira, Daniele ^b  

^a UNIVERSIDADE DE FRANCA   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Chagas' disease; Melastomataceae; Miconia; Triterpenes; Trypanosoma cruzi

Indexed keywords

ANTITRYPANOSOMAL AGENT; MICONIA EXTRACT; OLEANOLIC ACID; PLANT EXTRACT; TRITERPENE; UNCLASSIFIED DRUG; URSOLIC ACID;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOLYSIS; DRUG ACTIVITY; DRUG EFFECT; DRUG STRUCTURE; IN VITRO STUDY; IN VIVO CULTURE; MELASTOMATACEAE; MOUSE; NONHUMAN; SURVIVAL TIME;

ANIMALS; MELASTOMATACEAE; MICE; MOLECULAR STRUCTURE; STRUCTURE-ACTIVITY RELATIONSHIP; TRITERPENES; TRYPANOCIDAL AGENTS; TRYPANOSOMA CRUZI;

ANIMALIA; MICONIA; TRYPANOSOMA CRUZI;

EID: 33745473017     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.1881     Document Type: Article

References (15)

1. Bastos JK, Albuquerque S, Silva MLA. 1999. Evaluation of trypanocidal activity of lignans isolated from the leaves of Zanthoxylum naranjillo. Planta Med 65: 541-544.
2. Boza SS, Cassels BK. 1996. Plant metabolites active against Trypanosoma cruzi. Planta Med 62: 98-105.
3. Coll JC, Bowden BF. 1986. The application of vacuum liquid chromatography to the separation of terpene mixtures. J Nat Prod 49: 934-936.
4. Coura JR, De Castro SL. 2002. A critical review on Chagas disease chemotherapy. Mem Inst Oswaldo Cruz 97: 3-24.
5. Cunha WR, Martins C, Ferreira DS, Crotti AEM, Lopes NP, Albuquerque S. 2003. In vitro trypanocidal activity of triterpenes from Miconia species. Planta Med 69: 470-472.
6. Furuya T, Yutaka O, Hayashi O, Hayashi C. 1987. Triterpenoids from Eucalyptus perriniana cutured cells. Phytochemistry 26: 715-719.
7. Grael CFF, Vichnewski W, De Souza GEP, Lopes JLC, Albuquerque S, Cunha WR. 2000. A study of the trypanocidal and analgesic properties from Lychnophora granmogolense (Duarte) Semir & Leitão Filho. Phytother Res 14: 203-206.
8. Kashiwada Y, Nagao T, Hashimoto A et al. 2000. Anti-aids agents 38. Anti-HIV activity of 3-O-acyl ursolic acid derivatives. J Nat Prod 63: 1619-1622.
9. Kim YK, Yoon SK, Ryu SY. 2000. Cytotoxic triterpenes from stem bark of Physocarpus intermedius. Planta Med d66: 485-486.
10. Macedo AM, Machado CR, Oliveira RP, Pena SD. 2004. Trypanosoma cruzi: genetic structure of populations and relevance of genetic variability to the pathogenesis of Chagas disease. Mem Inst Oswaldo Cruz 99: 1-12.
11. 13C NMR spectra of pentacyclic triterpenoids-a compilation and some salient features (review). Phytochemistry 31: 1517-1575.
12. Muelas-Serrano S, Nogal-Ruiz JJ, Gómez-Barrio A. 2000. Setting of a colorimetric method to determine the viability of Trypanosoma cruzi epimastigotes. Parasitol Res 86: 999-1002.
13. Praia A. 2001. Clinical and epidemiological aspects of Chagas disease. Lancet Infect Dis 1: 92-100.
14. WHO. 2000. Special Programme for Research and Training in Tropical Disease (TDR). Natural products for parasitic diseases. TDR News 62: 4.
15. WHO. 2001. Chagas' disease intervention development and implemention research: transfer to the WHO regional office for the Americas. TDR News 66.